Episode 2

Centralised and Decentralised Procedures

Different approval pathways can be explored while entering the European pharmaceutical market. Our experts discuss the most explored approval pathways for product approval, CP and DCP, within the European Union (EU).

Reference Links

• EMA overview of the centralised authorisation procedure
• European Commission summary of national authorization procedures
• CMDh guidance on marketing authorization applications